BioSpace News Archive

Business

St. Joseph’s Children’s Hospital Patient with Extremely Rare Condition Travels to Nation’s Capital to Urge Congress to Safeguard Medicaid for Kids

This week, 5-year-old Lucia “Lucy” Ferlita joined nearly 50 other pediatric patients from across the nation on Capitol Hill to speak out on behalf of kids with complex medical conditions and encourage Congress to support legislation that keeps children’s health care needs top of mind.

June 29, 2018
·
3 min read
Business

Antibe Therapeutics Reports 2018 Year-End Financial and Operating Results

Antibe Therapeutics Inc. filed its financial and operating results on Friday, June 29 for the fourth quarter and the year ended March 31, 2018.

June 29, 2018
·
4 min read
Sunniva Inc. Announces Voting Results From Annual General and Special Meeting of Shareholders

Sunniva Inc. is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders held on June 27, 2018.

June 29, 2018
·
2 min read
Policy

FPT Communique - Health Ministers’ Meeting (HMM)

Federal, provincial and territorial (FPT) health ministers concluded a successful meeting today in Winnipeg, Manitoba.

June 29, 2018
·
6 min read
Policy

WeissLaw LLP Investigates Keryx Biopharmaceuticals Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Keryx Biopharmaceuticals Inc.

June 29, 2018
·
2 min read
Job Trends

Fagron Sterile Services Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL and Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL, in a 5mL Syringe Due to Mislabeling

Fagron Sterile Services is voluntarily recalling two (2) lots of Neostigmine Methylsulfate 5mL syringes to the user/hospital/clinic level.

June 29, 2018
·
3 min read
Business

Biogen Increases Ownership in Samsung Bioepis

Cambridge, Massachusetts-based Biogen exercised its option to acquire additional shares of Samsung Bioepis, a joint venture with Samsung BioLogics that was founded in 2012.

June 29, 2018
·
3 min read
·
Mark Terry
Business

Acceleron and Celgene Blood Disease Drug Luspatercept Hits The Mark in Phase III Trial

Acceleron Pharma plans to seek regulatory approval next year for its investigational drug luspatercept. The treatment hit its Phase III endpoints.

June 29, 2018
·
2 min read
·
Alex Keown
Business

Novartis to Spin off Its Alcon Eye Care Business

Switzerland-based Novartis announced it plans to spin off Alcon, its eye care division, into a separately-traded standalone company.

June 29, 2018
·
2 min read
·
Mark Terry
Business

Galapagos Plunges Following Mixed CF Trial Results and AbbVie Decision to Walk Away From Collaboration

Shares of Galapagos NV fell more than 15 percent Thursday afternoon and continued to fall in premarket trading after the Belgium-based company said AbbVie opted to walk away from its cystic fibrosis collaboration.

June 29, 2018
·
2 min read
·
Alex Keown